Clinical Trial Update: A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating MTP-131 topical ophthalmic solution for diabetic macular edema and non-exudati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema

Drugs mentioned

• MTP-131 Topical Ophthalmic Solution (MTP-131)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Diabetic Macular Edema, Age-related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED